Literature DB >> 16640587

Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes.

Judy Higgins1, Anthony Loughman, Kok P M van Kessel, Jos A G van Strijp, Timothy J Foster.   

Abstract

Staphylococcus aureus is a major cause of nosocomial and community-acquired infection. It expresses several factors that promote avoidance of phagocytosis by polymorphonuclear leucocytes. Clumping factor A (ClfA) is a fibrinogen-binding surface protein of S. aureus that is an important virulence factor in several infection models. This study investigated whether ClfA is an antiphagocytic factor, and whether its antiphagocytic properties were based on its ability to bind fibrinogen. In S. aureus, ClfA was shown to be of equal importance to protein A, the antiphagocytic properties of which are well established. ClfA expressed in a surrogate Gram-positive host was also found to be antiphagocytic. A ClfA mutant that was unable to bind fibrinogen had a similar antiphagocytic effect to native ClfA in the absence of fibrinogen. ClfA inhibited phagocytosis in the absence of fibrinogen, and showed enhanced inhibition in the presence of fibrinogen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16640587     DOI: 10.1111/j.1574-6968.2006.00229.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  49 in total

Review 1.  Innate Immune Signaling Activated by MDR Bacteria in the Airway.

Authors:  Dane Parker; Danielle Ahn; Taylor Cohen; Alice Prince
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

2.  Staphylococcus aureus: an introduction.

Authors:  Ian A Myles; Sandip K Datta
Journal:  Semin Immunopathol       Date:  2012-01-27       Impact factor: 9.623

Review 3.  Antistaphylococcal vaccines and immunoglobulins: current status and future prospects.

Authors:  Stan Deresinski
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  Piezotolerant small-colony variants with increased thermotolerance, antibiotic susceptibility, and low invasiveness in a clonal Staphylococcus aureus population.

Authors:  Kimon A G Karatzas; Angelos Zervos; Chrysoula C Tassou; Costas G Mallidis; Tom J Humphrey
Journal:  Appl Environ Microbiol       Date:  2007-01-26       Impact factor: 4.792

5.  Molecular characterization of the interaction of staphylococcal microbial surface components recognizing adhesive matrix molecules (MSCRAMM) ClfA and Fbl with fibrinogen.

Authors:  Joan A Geoghegan; Vannakambadi K Ganesh; Emanuel Smeds; Xiaowen Liang; Magnus Höök; Timothy J Foster
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

6.  Regional profiling for determination of genotype diversity of mastitis-specific Staphylococcus aureus lineage in Canada by use of clumping factor A, pulsed-field gel electrophoresis, and spa typing.

Authors:  Kamaleldin B Said; Johanne Ismail; Jennifer Campbell; Michael R Mulvey; Anne-Marie Bourgault; Serge Messier; Xin Zhao
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

Review 7.  Fibrinogen Is at the Interface of Host Defense and Pathogen Virulence in Staphylococcus aureus Infection.

Authors:  Ya-Ping Ko; Matthew J Flick
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

Review 8.  Staphylococcus aureus Aggregation and Coagulation Mechanisms, and Their Function in Host-Pathogen Interactions.

Authors:  H A Crosby; J Kwiecinski; A R Horswill
Journal:  Adv Appl Microbiol       Date:  2016-08-04       Impact factor: 5.086

Review 9.  The rise and rise of Staphylococcus aureus: laughing in the face of granulocytes.

Authors:  S Anwar; L R Prince; S J Foster; M K B Whyte; I Sabroe
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

10.  Staphylococcus aureus synthesizes adenosine to escape host immune responses.

Authors:  Vilasack Thammavongsa; Justin W Kern; Dominique M Missiakas; Olaf Schneewind
Journal:  J Exp Med       Date:  2009-09-28       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.